why choose us

First received: March 14, 2023

Clinical Trial: Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol

Study Status: Completed

Recruit Status: RECRUITING

Condition: Elevated Low-Density Lipoprotein Cholesterol

Study Type: INTERVENTIONAL


Official Title: Phase 1, Single Multiple Dose Escalation Study in a Randomized, Double-blind, Placebo Controlled Design to Investigate Safety, Tolerability, PK and PD of SC Administered SNK-396 in Subjects With Eleva

Brief Summary: This is a Phase 1, multi-center, randomized, double-blinded, placebo-controlled single and multiple dose escalation study with SC doses of SNK-396 in participants with elevated LDL-C.The study will be divided into two parts:SAD cohortsMAD cohorts

Read more